Parkin-Deficient Dopaminergic Neurons
Introduction <table class="infobox infobox-cell">
Parkin Deficient Dopaminergic [Neurons](/entities/neurons) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Parkin (PARK2) deficiency causes autosomal recessive juvenile [Parkinson's disease](/diseases/parkinsons-disease) (AR-JP). Parkin is an E3 ubiquitin ligase essential for mitophagy, and its loss leads to accumulation of damaged mitochondria and progressive dopaminergic neuron degeneration. [@youle2011]
Overview This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to [Alzheimer's disease](/diseases/alzheimers-disease), Parkinson's disease, and related conditions. [@pickrell2015]
<!-- taxonomy-enrichment --> [@narendra2008]
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links ...
Parkin-Deficient Dopaminergic Neurons
Introduction <table class="infobox infobox-cell">
Parkin Deficient Dopaminergic [Neurons](/entities/neurons) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Parkin (PARK2) deficiency causes autosomal recessive juvenile [Parkinson's disease](/diseases/parkinsons-disease) (AR-JP). Parkin is an E3 ubiquitin ligase essential for mitophagy, and its loss leads to accumulation of damaged mitochondria and progressive dopaminergic neuron degeneration. [@youle2011]
Overview This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to [Alzheimer's disease](/diseases/alzheimers-disease), Parkinson's disease, and related conditions. [@pickrell2015]
<!-- taxonomy-enrichment --> [@narendra2008]
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000700)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)
[OBO Foundry (CL:0000700)](http://purl.obolibrary.org/obo/CL_0000700)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)
Molecular Pathophysiology
Parkin Function
E3 ubiquitin ligase that tags damaged [mitochondria](/mechanisms/mitochondrial-dysfunction)
Mediates ubiquitination of mitochondrial proteins
Recruits [autophagy](/mechanisms/autophagy) receptors (p62, OPTN, NDP52)
Forms parkin bodies at mitochondrial clusters
[PINK1](/genes/pink1)-dependent recruitment to depolarized mitochondria
Loss-of-Function Mechanisms
Failure to ubiquitinate damaged mitochondria
Impaired [mitophagy](/mechanisms/mitophagy-defect) initiation
Accumulation of dysfunctional mitochondria
Failed mitochondrial turnover
[Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) cascades to cellular death
PINK1-Parkin Pathway
[PINK1](/genes/pink1) kinase accumulates on damaged mitochondria
Phosphorylates [parkin](/genes/park2) and ubiquitin
Triggers parkin activation and translocation
[Ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) recognition
Neuropathology
Mitochondrial Abnormalities
Enlarged and swollen mitochondria
Reduced cristae density
Decreased respiratory chain activity (complex I deficiency)
Increased mitochondrial DNA deletions
[Oxidative stress](/mechanisms/oxidative-stress) accumulation
Cellular Pathology
Progressive loss of dopaminergic neurons in [SNpc](/brain-regions/substantia-nigra)
Reduced dopamine transporter (DAT) activity
Increased [alpha-synuclein](/proteins/alpha-synuclein) aggregation
[Lewy body](/diseases/parkinsons-disease) formation
[Synaptic dysfunction](/mechanisms/synaptic-dysfunction-pathway)
Protein Homeostasis
[Autophagy-lysosome pathway](/mechanisms/autophagy-lysosome-pathway) impairment
[Ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) dysfunction
[Protein aggregation](/mechanisms/protein-aggregation) stress
[ER stress](/mechanisms/endoplasmic-reticulum-stress) response
Disease Mechanisms
Autosomal Recessive Juvenile Parkinsonism (AR-JP)
[PARK2](/genes/park2) (parkin) mutations cause earliest-onset PD
[PINK1](/genes/pink1) mutations second most common
[DJ-1](/genes/dj-1) and [ATP13A2](/genes/atp13a2) also implicated
Loss of dopaminergic neurons in [substantia nigra](/brain-regions/substantia-nigra)
Neuroinflammation
[Microglial activation](/mechanisms/neuroinflammation) in [substantia nigra](/brain-regions/substantia-nigra)
[Neuroinflammation](/mechanisms/neuroinflammation) exacerbates neurodegeneration
[Astrocyte](/cell-types/astrocytes) response in parkin deficiency
[Oxidative stress](/mechanisms/oxidative-stress) drives inflammation
Calcium Dysregulation
[Calcium dysregulation](/mechanisms/calcium-dysregulation-alzheimers) in dopaminergic neurons
Mitochondrial calcium overload
Pacemaker channel dysfunction
[Excitotoxicity](/mechanisms/excitotoxicity) risk
Research Models and Findings
Genetic Models
[PARK2](/genes/park2) knockout mice with mitochondrial defects
Drosophila parkin mutants with neurodegeneration
[iPSC](/cell-types/neurons-derived-from-pluripotent-stem-cells)-derived neurons from AR-JP patients
CRISPR-corrected isogenic lines for mechanistic studies
Phenotypic Markers
Loss of TH-positive neurons in [substantia nigra](/brain-regions/substantia-nigra)
Increased [apoptosis](/entities/apoptosis) markers (caspase-3, TUNEL)
[Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) indicators (JC-1, Seahorse)
[Autophagic flux](/mechanisms/autophagy-lysosome-pathway) impairment (LC3-II accumulation)
Therapeutic Approaches
Gene Therapy
AAV-PARK2 delivery to [substantia nigra](/brain-regions/substantia-nigra)
[CRISPR](/technologies/crispr-gene-editing)-mediated correction of mutations
Parkin protein replacement via AAV
[Nurr1](/proteins/nurr1-protein) and [Pitx3](/proteins/pitx3-protein) co-expression
Pharmacological
[Mitophagy-inducing](/mechanisms/mitophagy-defect) compounds (urolithin A, rapamycin)
[Mitochondrial protective agents](/therapeutics/neuroprotection) (CoQ10, MitoQ)
[Ubiquitination](/mechanisms/ubiquitin-proteasome-system) pathway modulators
[Anti-inflammatory](/mechanisms/neuroinflammation) agents
Cell Replacement
[iPSC](/cell-types/neurons-derived-from-pluripotent-stem-cells)-derived dopaminergic neurons
[Embryonic stem cell](/cell-types/neurons-derived-from-pluripotent-stem-cells)-derived neurons
Autologous cell therapy approaches
See Also
[Parkinson's Disease](/diseases/parkinsons-disease)
[Substantia Nigra](/brain-regions/substantia-nigra)
[PINK1](/genes/pink1)
[PARK2](/genes/park2)
[DJ-1](/genes/dj-1)
[Alpha-Synuclein](/proteins/alpha-synuclein)
[Mitophagy](/mechanisms/mitophagy-defect)
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
[Neuroinflammation](/mechanisms/neuroinflammation)
[Neuroprotection](/therapeutics/neuroprotection)
[Dopamine](/entities/dopamine)
Show full description